Barclays PLC Evogene Ltd. Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.63 - $2.83 $81 - $141	-50 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.45 - $3.45 $159 - $224	-65 Reduced 56.52%	50 $0
Q2 2021 Aug 13, 2021	BUY	$3.3 - $5.02 $224 - $341	68 Added 144.68%	115 $0
Q1 2021 May 13, 2021	BUY	$4.29 - $9.94 $201 - $467	47 New	47 $0
Q2 2020 Aug 12, 2020	SELL	$0.92 - $1.29 $640 - $897	-696 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.37 - $1.7 $397 - $493	-290 Reduced 29.41%	696 $1,000
Q1 2019 May 15, 2019	BUY	$1.83 - $2.38 $1,804 - $2,346	986 New	986 $2,000
Q4 2018 Feb 14, 2019	SELL	$1.98 - $3.01 $97,673 - $148,483	-49,330 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.24 - $5.06 $209,159 - $249,609	49,330	49,330 $219,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.